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Summary
Objective: Osteoarthritis is currently diagnosed utilizing X-ray and MRI-techniques, both of which are based on the morphological changes
of tissue. However, once changes are detected, the tissue has an irreversible defect. This study investigates early diagnosis of OA on a
molecular basis using a recently developed cathepsin B sensitive near-infrared (NIR) fluorescent probe.
Method: Twelve male nude mice were induced osteoarthritis by intra-articular injection of collagenase (1.0%, w/v) into the right knee joint.
The left knee joint served as the negative control. The cathepsin B NIR probe is activated by arthritis-associated cathepsin B, thus resulting
in the emission of an intensive NIR fluorescence signal which can be detected in vivo. NIR fluorescence signals were acquired on an optical
imaging system using an excitation wavelength of 610–650 nm and an emission wavelength of 680–720 nm.
Results: Mild to moderate degenerative cartilage was observed 1 month after collagenase injection. NIR fluorescence imaging of mice
showed approximately a 3-fold difference in signal intensity between osteoarthritic and normal joints 24 h after intravenous injection of the
reporter probe. Immunohistochemical evaluation also revealed cathepsin B expression in the arthritic lesion of femorotibia joints, and not in
the control contra-lateral knee joints.
Conclusion: As the cathepsin B activatable NIR fluorescent imaging showed a significant difference between the osteoarthritic and normal
joints, the cathepsin B activatable NIR fluorescent probe thus offers a potential new imaging technology for early OA diagnosis.
© 2003 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Introduction
Osteoarthritis (OA) is the most common form of arthritis
worldwide. It is estimated that 11% of individuals 65 years
of age have symptomatic knee OA. On average, 16 to 21
million Americans are attacked yearly by OA, and the
number is expected to increase to 40 million by 2020 as the
population ages1. OA is a complex, progressive disease of
the joint characterized by degenerative and regenerative
morphological and structural alteration. This process leads
to fibrillation, erosion of articular cartilage, proliferation of
normally non-dividing chondrocytes, formation of osteo-
phytes at joint margins, and sclerosis of subchondral bone
resulting in joint dysfunction at the late stage of the dis-
ease2,3. The etiopathogenesis of osteoarthritis is multifac-
torial and not completely elucidated. However, the common
feature of osteoarthritis is characterized by the early inflam-
mation followed by degeneration of chondrocytes including
irreversible biodegradation of proteoglycan and type II
collagen in articular cartilage4,5.
Currently, OA is diagnosed by X-ray and MRI. The X-ray
is utilized to detect hard tissue changes, while the MRI is
more sensitive to detect soft tissue defects6. These detec-
tions are all based on morphological changes of tissue.
Once the changes are seen on the X-ray or MRI, the tissue
already appears an irreversible defect. Clinically, it is
strongly believed that early control of the disease process
is the best therapy. Hence, the accurate diagnosis of OA at
its early stage is highly demanded.
High level of activity of an extracellular cysteine pro-
tease, cathepsin B, has been found around clefts and in the
zones of hypercellularity in osteoarthritic cartilage7. High
intracellular activity of cathepsin B was also found in
degenerated chondrocytes7 and synovium8. The particular
distribution of cathepsin B suggested that it may play a
critical role in cartilage catabolism in osteoarthritis9. Poten-
tially this enzyme can be used as a biological marker to
study OA.
Recently, a series of protease sensitive near-infrared
fluorescence (NIRF) probes for in vivo imaging of
disease-associated proteases were developed in this
laboratory 10–13. The probes were designed to have a low
fluorescence signal in their initial state, due to serious
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self-quenching between multiple near-infrared (NIR) fluoro-
chromes. The NIRF signal is not released until the probe is
recognized and activated (digested) by the targeted pro-
tease. The cathepsin B selective probe has previously
been applied to tumor detection, tumor characterization,
and atherosclerotic plaque localization in vivo10,14–17. With
these findings, we thus hypothesize that cathepsin B probe
may be used in early OA diagnosis. Using an OA mouse
model, we are able to demonstrate that the cathepsin B
probe can be activated in the osteoarthritic joints at an early
stage of the disease.
Materials and methods
GENERAL
Bacterial collagenase and most histological reagents
were purchased from Sigma (St Louis, MO), unless specifi-
cally mentioned. Cathepsin B sensitive probe consisting
Cy5.5 fluorochromes was synthesized as previously pub-
lished10. Briefly, a synthetic graft copolymer consisting of
poly-L-lysine (35 kDa) sterically protected by multiple meth-
oxypolyethylene glycol (5 kDa) side chains was used as a
delivery vehicle of quenched fluorochromes. About 30% of
the lysine residues were PEG-ylated, 15% were reacted
with Cy5.5 and the rest 55% were remained free. The
overall molecular weight of the probe is about 500 kDa. The
free lysine residues on the backbone serve as sites for
cleavage by cathepsin B10.
INDUCTION OF OSTEOARTHRITIS
Twelve 10-week-old, male nude mice were used in this
study (Charles River Lab, Wilmington, MA). The animals
were housed in cages with a sawdust bottom in an air-
conditioned room at constant temperature and were fed a
standard laboratory diet. All animal studies were approved
by the Subcommittee on Research Animal Care at
Massachusetts General Hospital. Ketamine (80 mg/kg
of body weight) and Xylazine (12 mg/kg) delivered
subcutaneously were used as anesthetics, and for
euthanasia, pentobartobital (100 mg/kg) was administered
intraperitoneally.
The collagenase-induced osteoarthritis in mouse was
adapted from a previously described model18,19. The
bacterial collagenase 1.0% (w/v) solution was prepared
and filtered through a 0.2 µm bacteria filter. The right knee
joint of mouse was injected once (22s needle, Hamilton,
Reno, Nevada), intra-articularly through the patellar
ligament, with 10 µl of the collagenase solution. The left
control knee was injected with the same volume of normal
saline.
IN VIVO IMAGING
One month after the induction of OA, each mouse was
injected systemically with 2 nmole of cathepsin B probe.
Twenty-four hours later, the animals were anesthetized and
whole body optical imaging using a laboratory-built optical
imaging system was performed20. The system contained a
150 W halogen lamp with an excitation and an emission
bandpass filter of 610–650 nm and 680–720 nm, respect-
ively (Omega Optical, Brattleboro, VT). Both white light and
NIRF images were detected by a 12-bit CCD camera
(Kodak, Rochester, NY). Whole-body NIRF images were
Fig. 1. Near infrared fluorescence reflectance imaging 24 h after IV
injection of the cathepsin B sensitive autoquenched probe in a
representative animal; (A and B) white light images, (C and D)
NIRF images. Note that the arthritic knee joints reveal significantly
higher joint tissue fluorescence values compared to contralateral
joints.
Table I
NIRF signal intensity of osteoarthritic joints compared to control
joints. Near infrared fluorescence signal intensity (680–720 nm)
24 h after IV injection of the cathepsin B sensitive probe in 12
animals: P<0.0001
Mouse OA joint Control joint OA/Control
#1 481.0 160.0 3.0
#2 404.0 79.8 5.1
#3 230.2 107.8 2.1
#4 548.3 106.3 5.2
#5 251.4 84.4 3.0
#6 245.7 93.0 2.6
#7 299.2 148.8 2.0
#8 337.6 146.5 2.3
#9 305.9 160.6 1.9
#10 412.8 171.6 2.4
#11 392.5 136.3 2.9
#12 218.2 87.6 2.5
Mean 343.9 123.6 2.8
SD 105.2 33.8
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obtained with acquisition times of 2 min, and the white light
images were with 0.075 s.
IMMUNOHISTOCHEMISTRY
After imaging, animals were euthanasized and knee joint
tissues were sagittally excised en bloc. Specimens were
fixed in formalin for 5 days, and subsequently decalcified in
5% formic acid for 4 days. Standard processing of the
tissue processing apparatus was followed by embedding
the knee joints in paraffin and serial sectioned (10 µm).
Tissue sections were stained with hematoxylin/eosin and
the arthritic areas were evaluated using a cartilage and
synovium score ranging from 0 (no alterations), + (mild
pathological alterations), ++ (moderate pathological
alterations), to +++ (markedly pathological alterations).
Ten µm thick tissue sections were selected from formalin-
fixed paraffin-blocks, deparaffinized with xylene and rinsed
three times with 100% ethanol and once with distilled water.
The deparaffinized sections were pretreated with hyaluro-
nidase 1 mg/ml and collagenase 1 mg/ml in phosphate-
buffered saline for 1 h at 37°C and the staining procedure
was performed with a modification of the avidin–biotin–
peroxidase complex (ABC) technique21,22. The slides were
incubated with the primary antibody against cathepsin B
(1:40 dilution, sc-6493, Santa Cruz Biotechnology, Santa
Cruz, CA) for 18 h and with the secondary biotinylated
donkey antibody against goat-IgG (1:200 dilution, sc-2402,
Santa Cruz biotechnology) for 2 h at room temperature in
a humidified chamber. Thereafter, slides were rinsed
with PBS and visualized with a chromogen of oxidized
diaminobenzidine-H2O2 reaction. Positive immunoreac-
tions appeared as dark brown staining on a blue back-
ground; counterstaining was done with hematoxylin. All
processes were conducted at room temperature. Tissue
was viewed using a Nikon Eclipse 800 microscope and
images were digitally captured using a CCD-SPOT RT
digital camera and compiled using Adobe Photoshop™
software (v5.5).
STATISTICAL ANALYSIS
To quantitate NIRF signal, a circular region-of-interest
(ROI) was manually defined around the joint, and the
average signal within this ROI was obtained. Data are
presented mean±SD. Statistical analysis of different groups
was conducted using a two-tailed student t-test. A P-value
<0.05 was considered to be significant.
Results
According to the published protocol, mice will have mild
to moderate OA symptom 3 to 4 weeks after the intra-
articular injection of collagenase18,19. In our preparation,
the animals appeared normal as described except one
showed mild deformity on osteoarthritic joints at
1 month. The observed osteoarthritic alterations in the
collagenase model closely resembled previously published
studies.
To check if OA could be detected by NIRF imaging, the
cathepsin B probe was administered i.v. to the arthritic
mouse. A clearly detectable NIRF signal was observed in
the arthritic joint 2–3 h later, but the highest target to
background signal was observed at 24-h time point.
As seen on Fig. 1, a significantly higher NIRF signal
was found in the arthritic joints. The average signal
intensity was 2.8-fold higher in the osteoarthritic joints
compared to control joints 24 h after probe injection
(343±105 and 123±33 P<0.0001, Table I). More than 5-fold
of signal intensity difference between arthritic and control
Fig. 2. Histology, immunohistochemistry, and microscopic fluorescence of the control joint. (20×) (A) H/E staining indicated that the epiphysis
of the distal femur comprised cancellous bone covered by a thin layer of compact bone. The outer surface on the epiphysis appears smooth
and was covered with hyaline cartilage. The meniscal disc appeared normal. Chondrocytes and disc cells were found within the disc. (B)
Immunohistochemical staining for cathepsin B is not found in the normal knee joint. (C) NIRF signal was not detectable in the control joints.
Table II
Collagen-induced arthritis. Histologic evaluation of the osteoar-
thritic alteration in the collagenase injected (1%) knee joints of
individual mice (n=12)*
Pathological alteration 0 + ++ +++
Cartilage englargement 0 2 7 3
Cartilage fibrillation 0 0 9 3
Erosion of non-calcified cartilage 0 2 8 2
Erosion of calcified cartilage 4 5 3 0
Chondrocyte loss 0 5 7 0
Chondrocyte cluster 0 8 4 0
Synovial infiltration 0 8 4 0
Synovial hyperplasia 0 0 9 3
Erosion of bone 12 0 0 0
*Key: 0, no alterations; + mild pathological alterations; ++
moderate pathological alterations; +++ markedly pathological al-
terations.
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joints was observed after the removal of skin (data not
shown).
The histology sections of the contralateral control joints
appeared normal. The epiphyses were composed of
cancellous bone covered by a thin layer of compact bone,
and the outer surface on the epiphysis was covered with
hyaline cartilage (Fig. 2A). In contrast, osteoarthritic joints
showed mild to moderate deformity. An overview of the
osteoarthritic alterations is listed in Table II. The osteo-
arthritic lesions in the knee joint were moderate, but none
of animals have bone erosion at this time point. The
cartilage on the anterior aspect of the femorotibial joints
showed signs of degeneration, including fibrillation, cleft
formation and erosion (Fig. 3A). Moderate to marked
synovial proliferation was noted in the condylar process of
tibial and femoral bone. Granulation tissue and vascular
formation were found in the surface layer. Synovial
hyperplasia was also found on the edges of menisci (Fig.
3B and E).
To check if cathepsin-B expression correlated with
the cathepsin-B NIRF signal, immunohistochemistry was
performed with anti-cathepsin-B antibody. Cathepsin B
expression was noted in the arthritic lesion of femorotibia
joints. The majority of cathepsin B was distributed in
panni, hyperplasic synovium and in intracellular and
pericellular areas of degenerated chondrocytes (Fig. 3C
and F). Cathepsin-B expression was not detected in the
contralateral normal knee joints (Fig. 2B).
The NIRF signal distribution is histological sections cor-
related with that of cathepsin B, which is locally distributed
in the degenerated cartilage (Fig. 3C and D) and hyperplas-
tic synovium (Fig. 3F and G). As expected, the cathepsin B
Fig. 3. Histology, immunohistochemistry, and microscopic fluorescence of the arthritic joint. (A) Cartilage of the femorotibial joints shows mild
to moderate signs of degeneration. Fibrillation, clefting, erosion, and eburnation are noticed in this area. (10×) (B) Milder degeneration was
characterized by the degenerated chondrocytes and synovial villi formation (40×). (E) Synovial hyperplasia is found on the edges of the
meniscus. (C) Cathepsin B expression is found in the intra- and peri-cellular areas of degenerated chondrocytes (40×), and (F) in hyperplasic
synovium (40×). Near infrared fluorescence microscopy shows a significant fluorescence signal correlatively to the areas of cathepsin B
expression (D and G, 40×).
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(Fig. 2B) and NIRF signal (Fig. 2C) in contralateral joints
were minimally detectable.
Discussion
In this study we have used cathepsin B sensitive probes
with collagenase-induced osteoarthritic joint model to relate
NIRF signal with tissue parameters. One of the major
problems in OA is the low rate of matrix synthesis and the
inability of the chondrocytes to exceed the rate of matrix
degradation. These combined factors lead to the overall
destruction of the cartilage as seen in OA. Cartilage deg-
radation is mediated by elevated proteolytic activity of
enzymes and cathepsin B and several other proteases may
potentially participate in matrix degradation23. In exper-
imental osteoarthritis, cathepsin B is up-regulated in syno-
vial tissue during the early degenerative phase.
Furthermore, progression of experimental osteoarthritis is
accompanied by up-regulation of cathepsin-B in cartilage8.
Results in this research showed that the collagen-induced
osteoarthritic joints demonstrate pathological alterations
including erosion and fibrillation of cartilage, and synovial
hyperplasia. In histological sections, the microscopic NIRF
imaging also correlated with histopathological and immu-
nohistochemical findings. The immunohistochemical reac-
tion of cathepsin B was found in the inflamed joint tissues
such as degenerated chondrocytes and hyperplastic
synovial lining, but not in the normal joints. These results
agree with previous studies that cathepsin B participates in
articular cartilage catabolism in osteoarthritic joints24.
Chondrocytes from normal cartilage contained very few
lysosomes and only a minor cell population was cathepsin
B positive. A high proportion of chondrocytes from active
OA cartilage contained a large number of lysosomes and
an excess of cathepsin B in intracellular organelles; the
enzyme was also stored in an active form25. In this study,
minimal to no cathepsin B activity could be detected by
immunohistochemistry in either chondrocytes or matrix of
normal cartilage. Thus the cathepsin B may act as a
plausible marker to differentiate osteoarthritic joints from
normal joints. It has been reported that cathepsin B
reaches the highest level when macrophages were present
in the joint space 20 days after the induction of arthritis26.
This suggests that the macrophage infiltrate may have
stimulated proteinase production in chondrocytes through
cytokine release. The profile of proteinase expression also
suggests their involvement in the breakdown of cartilage
and bone in the arthritic joint26.
In humans, OA evolves slowly, and its diagnosis is
delayed because its initial phase activity is clinically silent.
In addition, current non-invasive imaging modality such as
radiography, computerized tomography (CT), magnetic
resonance imaging, and conventional ultrasonography (5–
10 MHz) only allow detection of permanent tissue change.
It has been suggested that MRI seems to be a more
sensitive way of detecting inflammation, and visualizing
destructive bone changes than the conventional radiogra-
phy in arthritis27. However, MRI is still not sensitive enough
in OA diagnosis. For example, recurrence of synovitis
presented in most knees can only be detected after 2
months.
Improvement in qualitative imaging of OA requires the
introduction of high resolution and reliable modalities
that allow assessment of the early changes of osteo-
arthritic joints at the molecular level. Imaging protease
activity using optical probes provides morphologic details at
the molecular basis. Our data showed the NIRF imaging on
the hyperplastic synovial lining and degenerated
chondrocytes from experimental osteoarthritis knees within
a month. The detectability of the NIRF signal at the early
arthritic stage shows that this non-invasive optical imaging
technology can potentially be used for early OA diagnosis.
In this study, cathepsin B acts as a biological marker for
OA. In addition to cathepsin B, there are other proteases
that may be also involved in the pathogenesis of OA,
and can serve as biomarkers. For example, metalloprotei-
nases, including stromelysin and collagenase, are a big
family of enzymes known to play key roles in cartilage
degradation23. Cathepsin K, a major osteoclastic pepti-
dase, is known to be involved in bone resorption24,28.
These proteases are also potential targets for OA
diagnosis.
In additional to target selection and probe optimization,
imaging systems play important roles in advancing this
technique into clinics. NIRF tomographic systems17 and
arthroscopes have to be developed for orthopedic appli-
cations. The potential disadvantage of using this optical
technology is still the fundamental limitation of light, diffu-
sion. Photons will be scattered in a complex environment
including tissue, cartilage, fluid, and bone. High resolution
image in patient joints could be a challenge.
In summary, cathepsin B was found up-regulated in
osteoarthritic chondrocytes as well as hyperplastic
synovium at an early stage of osteoarthritis. Such early
physiological changes can be detected using the devel-
oped cathepsin B sensitive NIRF probe. The imaging
technology may provide a new strategy for early detection
of osteoarthritis at the molecular level.
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